“Which provider is the lowest cost, highest quality, and is in my CIN?”
Payer
The National Committee for Quality Assurance ranked Group Health Cooperative of South Central Wisconsin and the Kaiser Foundation Health Plan of the Mid-Atlantic States the two best-performing commercial health plans in 2018-19.
The California Court of Appeal upheld regulations for fair claims settlements after a 10-year legal challenge, paving the way for $91 million in fines against a UnitedHealthcare subsidiary, the California Department of Insurance said Sept. 21.
Two South Carolina representatives want to meet with Blue Cross Blue Shield of South Carolina and several urgent care centers to address what they argue is an attempt by BCBS to limit competition among urgent care centers, according to the…
Aetna Chairman and CEO Mark Bertolini recently discussed myriad issues, including his childhood and career path, in an interview with The New York Times.
Advertisement
Blue Cross and Blue Shield of Rhode Island will pay $5 million toward a mental health fund after a state audit revealed the health insurer was not in compliance with state and federal laws, according to the Providence Journal.
Hospital systems ink exclusive contracts with various payers. These secret contracts often contain language barring health insurers from excluding market-dominant providers from their network or adding less-expensive rivals, according to The Wall Street Journal.
Independence Blue Cross in Pennsylvania is notifying an undisclosed number of plan members about a potential compromise of their protected health information after an employee uploaded a file containing personal data to a website that was publicly accessible for three…
The FDA-cleared Apple Watch Series 4 will allow wearers to take electrocardiograms on their wrists and receive alerts if their heartbeat becomes irregular, leaving some to question whether the device will count as a medical device for tax purposes, according…
CMS said Aug. 7 it will give private Medicare Advantage plans more negotiating power over prices for Part B drugs, which are administered in physician offices and hospitals, in an effort to reduce spending.